Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cell Metab. 2012 May 2;15(5):574-84. doi: 10.1016/j.cmet.2012.03.005.

Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.

Author information

  • 1Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease in Western societies, affecting one in four adults in the USA, and is strongly associated with hepatic insulin resistance, a major risk factor in the pathogenesis of type 2 diabetes. Although the cellular mechanisms underlying this relationship are unknown, hepatic accumulation of diacylglycerol (DAG) in both animals and humans has been linked to hepatic insulin resistance. In this Perspective, we discuss the role of DAG activation of protein kinase Cε as the mechanism responsible for NAFLD-associated hepatic insulin resistance seen in obesity, type 2 diabetes, and lipodystrophy.

Copyright © 2012 Elsevier Inc. All rights reserved.

PMID:
22560210
[PubMed - indexed for MEDLINE]
PMCID:
PMC3353749
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk